DKCM
BCAB icon

Davidson Kempner Capital Management’s BioAtla BCAB Stock Holding History

Davidson Kempner Capital Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-200
Closed -$340K – 469
2020
Q4 		$340K Buy
+200
New +$334K ﹤0.01% 262

Other funds holding BCAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Davidson Kempner Capital Management's BCAB Position: Q1 2021 in Review

Davidson Kempner Capital Management sold out of BioAtla (BCAB) in Q1 2021, closing a stake of 200 shares — an estimated $340K sold.

Davidson Kempner Capital Management first reported a position in BCAB in Q4 2020 and held it in 1 quarter. The position peaked at $340K in Q4 2020. 62 funds tracked by Wall St. Rank hold BCAB as of Q1 2021.

  • Davidson Kempner Capital Management reported no remaining BioAtla position as of Q1 2021 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 200 BioAtla shares in Q1 2021, an estimated $340K.
  • Davidson Kempner Capital Management first reported a position in BioAtla in Q4 2020 and held it in 1 quarter.
  • Davidson Kempner Capital Management's BioAtla position peaked at $340K in Q4 2020.
  • 62 funds tracked by Wall St. Rank held BioAtla as of Q1 2021.

Based on Davidson Kempner Capital Management's 13F filing for Q1 2021, filed 17 May 2021.